Issue 39, 2025

MD-enhanced DFT investigation of β-cyclodextrin as drug delivery system for Ampyra drug

Abstract

Cyclodextrins (CDs) have emerged as a promising strategy for the targeted drug delivery process. Herein, the potential of β-cyclodextrin (β-CD) as a drug delivery system for the Ampyra (AMP) drug was extensively investigated. By means of the molecular dynamics (MD) simulation technique, the inclusion process of AMP with β-CD was first examined and consequently subjected to clustering analysis. Upon the obtained five configurations (A↔E) of AMP⋯β-CD complex, extensive density functional theory (DFT) calculations were executed. The favorability of the quested encapsulation process was affirmed by negative adsorption and interaction energies of the selected configurations A↔E affirmed the occurrence of the quested encapsulation process. In particular, configuration A is more energetically preferred compared to other analogs. The insights from SAPT analysis verified the dominant role of electrostatic and dispersion forces in the interactions within the studied configurations A↔E. From QTAIM and NCI analyses, the occurrence and nature of intermolecular interactions within the studied configurations A↔E were illustrated. As per the electronic analysis, the effect of the AMP encapsulation process on the electronic features of β-CD was emphasized. The enhancing impact of the aqueous medium on the studied configurations A↔E was verified by negative adsorption and solvation energies. Moreover, the calculated recovery time values pinpointed the separation potential of AMP from β-CD at the target cell. Overall, the obtained outcomes provided insights into the potential application of β-CD as a drug delivery system, particularly for AMP drug.

Graphical abstract: MD-enhanced DFT investigation of β-cyclodextrin as drug delivery system for Ampyra drug

Supplementary files

Article information

Article type
Paper
Submitted
18 Jun 2025
Accepted
14 Aug 2025
First published
10 Sep 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 32626-32637

MD-enhanced DFT investigation of β-cyclodextrin as drug delivery system for Ampyra drug

A. S. M. Rady, P. A. Sidhom, L. A. Mohamed, K. E. Ibrahim, S. Khan and M. A. A. Ibrahim, RSC Adv., 2025, 15, 32626 DOI: 10.1039/D5RA04351D

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements